METHOTREXATE SODIUM PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methotrexate Sodium Preservative Free, and what generic alternatives are available?
Methotrexate Sodium Preservative Free is a drug marketed by Accord Hlthcare, Eugia Pharma Speclts, Hikma, Hospira, Mylan, Pharmachemie Bv, Sagent Pharms Inc, and Sandoz. and is included in thirteen NDAs.
The generic ingredient in METHOTREXATE SODIUM PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methotrexate Sodium Preservative Free
A generic version of METHOTREXATE SODIUM PRESERVATIVE FREE was approved as methotrexate sodium by HIKMA on September 16th, 1986.
Summary for METHOTREXATE SODIUM PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 13 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 1 |
Patent Applications: | 4,936 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METHOTREXATE SODIUM PRESERVATIVE FREE at DailyMed |
Recent Clinical Trials for METHOTREXATE SODIUM PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cooperative Study Group A for Hematology | Phase 3 |
See all METHOTREXATE SODIUM PRESERVATIVE FREE clinical trials
Pharmacology for METHOTREXATE SODIUM PRESERVATIVE FREE
Drug Class | Folate Analog Metabolic Inhibitor |
Mechanism of Action | Folic Acid Metabolism Inhibitors |